104 related articles for article (PubMed ID: 1822776)
1. Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure.
Makover A; Zuk D; Breakstone J; Yaffe D; Nudel U
Neuromuscul Disord; 1991; 1(1):39-45. PubMed ID: 1822776
[TBL] [Abstract][Full Text] [Related]
2. A housekeeping type promoter, located in the 3' region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene.
Lederfein D; Yaffe D; Nudel U
Hum Mol Genet; 1993 Nov; 2(11):1883-8. PubMed ID: 8281151
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene.
Gilgenkrantz H; Hugnot JP; Lambert M; Chafey P; Kaplan JC; Kahn A
J Biol Chem; 1992 May; 267(15):10823-30. PubMed ID: 1316911
[TBL] [Abstract][Full Text] [Related]
5. Developmental and tissue-specific regulation of mouse dystrophin: the embryonic isoform in muscular dystrophy.
Geng Y; Sicinski P; Gorecki D; Barnard PJ
Neuromuscul Disord; 1991; 1(2):125-33. PubMed ID: 1822783
[TBL] [Abstract][Full Text] [Related]
6. Multiple products of the Duchenne muscular dystrophy gene.
Yaffe D; Makover A; Lederfein D; Rapaport D; Bar S; Barnea E; Nudel U
Symp Soc Exp Biol; 1992; 46():179-88. PubMed ID: 1341034
[TBL] [Abstract][Full Text] [Related]
7. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
8. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene.
Rapaport D; Lederfein D; den Dunnen JT; Grootscholten PM; Van Ommen GJ; Fuchs O; Nudel U; Yaffe D
Differentiation; 1992 Apr; 49(3):187-93. PubMed ID: 1377655
[TBL] [Abstract][Full Text] [Related]
9. PCR analysis of dystrophin gene mutation and expression.
Chamberlain JS; Farwell NJ; Chamberlain JR; Cox GA; Caskey CT
J Cell Biochem; 1991 Jul; 46(3):255-9. PubMed ID: 1774226
[TBL] [Abstract][Full Text] [Related]
10. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy.
Muntoni F; Melis MA; Ganau A; Dubowitz V
Am J Hum Genet; 1995 Jan; 56(1):151-7. PubMed ID: 7825571
[TBL] [Abstract][Full Text] [Related]
11. TATA-less mouse vitronectin gene promoter: characterization of the transcriptional regulatory elements and a nuclear protein binding site on the promoter.
Miyamoto Y; Hara K; Matsumoto Y; Hayashi M
Cell Struct Funct; 1998 Feb; 23(1):23-32. PubMed ID: 9639027
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin is transcribed in brain from a distant upstream promoter.
Boyce FM; Beggs AH; Feener C; Kunkel LM
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1276-80. PubMed ID: 1996328
[TBL] [Abstract][Full Text] [Related]
13. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution.
Bar S; Barnea E; Levy Z; Neuman S; Yaffe D; Nudel U
Biochem J; 1990 Dec; 272(2):557-60. PubMed ID: 2176467
[TBL] [Abstract][Full Text] [Related]
14. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles.
Pichavant C; Chapdelaine P; Cerri DG; Bizario JC; Tremblay JP
Hum Gene Ther; 2010 Nov; 21(11):1591-601. PubMed ID: 20553115
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle.
Khurana TS; Watkins SC; Chafey P; Chelly J; Tomé FM; Fardeau M; Kaplan JC; Kunkel LM
Neuromuscul Disord; 1991; 1(3):185-94. PubMed ID: 1822793
[TBL] [Abstract][Full Text] [Related]
16. Glial fibrillary acidic protein transcriptional regulation is independent of a TFIID-binding downstream initiator sequence.
Hatch N; Sarid J
J Neurochem; 1994 Dec; 63(6):2003-9. PubMed ID: 7964717
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
[TBL] [Abstract][Full Text] [Related]
18. Brain- and muscle-type promoters of the dystrophin gene are selected in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid [correction of lymphoplastoid] cells.
Nishio H; Matsuo M; Kitoh Y; Narita N; Shimmoto M; Suzuki Y; Nakamura H
J Neurol; 1993 Dec; 241(2):81-6. PubMed ID: 8138829
[TBL] [Abstract][Full Text] [Related]
19. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus.
Lidov HG; Selig S; Kunkel LM
Hum Mol Genet; 1995 Mar; 4(3):329-35. PubMed ID: 7795584
[TBL] [Abstract][Full Text] [Related]
20. Reporter gene expression upon stable transfection when only a TATA box or a TATA box plus Sp1 sites are present 5' to the gene.
Warshamana GS; Qu GZ; Zhang XY; Ji W; Ehrlich M
DNA Cell Biol; 1995 Aug; 14(8):709-17. PubMed ID: 7646818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
